EU

EUGENE SCIENCE

Information

  • Mailing address
    16-7 SMJUNG-DONG, OJUNG-GU, BUCHEON, KYONGGI-DO, Delaware, 00000
  • Phone
    82-32-676-6283
  • State location
    Korea, Democratic People's Republic Of
  • State of incorporation
    Delaware
  • Fiscal year end
    December 31
  • SIC
    2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
  • Filings
    N/A

About EUGENE SCIENCE

EUGENE SCIENCE (CIK: 0001107685) is an American company incorporated in the state of Korea, Democratic People's Republic Of. Head office is located at 16-7 SMJUNG-DONG, OJUNG-GU, BUCHEON, KYONGGI-DO, Korea, Democratic People's Republic Of, 00000. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. EUGENE SCIENCE is a public company and trade via Over-The-Counter (OTC).

Old names:

  • EZCOMM ENTERPRISES INC from 2005-19-Oct to 2005-01-Dec
  • EZCOMM INC from 2004-20-Feb to 2005-11-Oct

Ownership

Owner Filings Transaction Date Type of Owner
LEE TAE HWAN 0001340973 May-31-2006 director, officer: SENIOR VP, SALES AND MARKETING
AHN SECHEON 0001340979 May-31-2006 director, officer: SENIOR VP, PRODUCTION
YOO JAE HONG 0001341000 May-31-2006 officer: CFO
Noh Seung Kwon 0001341009 May-31-2006 director, 10 percent owner, officer: PRESIDENT AND CEO
Kim Tony 0001340993 Sep-30-2005 director
Braun Peter 0001291185 May-20-2004 director, officer: Pres., Secy., Treas., Director

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by EUGENE SCIENCE

Filings Format Description Filed/Effective File/Film Number
REVOKED Document Acc-no: 9999999997-12-008277 (34 Act) Size: 23 KB Apr-24-2012

000-50601

12774686
UPLOAD Document Acc-no: 0000000000-09-032370 ( Act) Size: 42 KB Jun-18-2009

8-K Document

Current report filing

Acc-no: 0001144204-08-052097 (34 Act) Size: 227 KB		 Sep-10-2008

000-50601

081065141
UPLOAD Document Acc-no: 0000000000-08-043570 ( Act) Size: 15 KB Aug-28-2008

CORRESP Document

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Acc-no: 0001144204-08-049990 ( Act) Size: 12 KB		 Aug-27-2008

10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0001144204-08-048346 (34 Act) Size: 805 KB		 Aug-19-2008

000-50601

081026266
10KSB/A Document Acc-no: 0001144204-08-048117 (34 Act) Size: 110 KB Aug-18-2008

000-50601

081024419
NT 10-Q Document

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Acc-no: 0001144204-08-045222 (34 Act) Size: 43 KB		 Aug-11-2008

000-50601

081005570
UPLOAD Document Acc-no: 0000000000-08-036447 ( Act) Size: 46 KB Jul-22-2008

8-K Document

Current report filing

Acc-no: 0001144204-08-034273 (34 Act) Size: 28 KB		 Jun-09-2008

000-50601

08888683
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0001144204-08-031294 (34 Act) Size: 802 KB		 May-21-2008

000-50601

08850112
NT 10-Q Document

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Acc-no: 0001144204-08-030255 (34 Act) Size: 40 KB		 May-16-2008

000-50601

08841204
10KSB Document Acc-no: 0001144204-08-022023 (34 Act) Size: 1243 KB Apr-14-2008

000-50601

08754118
UPLOAD Document Acc-no: 0000000000-08-017349 ( Act) Size: 43 KB Apr-03-2008

NT 10-K Document

Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT

Acc-no: 0001144204-08-018097 (34 Act) Size: 55 KB		 Mar-28-2008

000-50601

08717856
UPLOAD Document Acc-no: 0000000000-08-014342 ( Act) Size: 55 KB Mar-18-2008

8-K Document

Current report filing

Acc-no: 0001144204-07-065202 (34 Act) Size: 280 KB		 Nov-30-2007

000-50601

071278215
8-K Document

Current report filing

Acc-no: 0001144204-07-063815 (34 Act) Size: 42 KB		 Nov-21-2007

000-50601

071262808
10QSB Document Acc-no: 0001144204-07-063143 (34 Act) Size: 1014 KB Nov-19-2007

000-50601

071256853
8-K/A Document

Amendment to Current report filing

Acc-no: 0001144204-07-062675 (34 Act) Size: 282 KB		 Nov-16-2007

000-50601

071253620

Recent 20 filings. View all EUGENE SCIENCE filings

Reviews

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Frequently Asked Questions

Tags:

  • EUGENE SCIENCE overview
  • EUGENE SCIENCE job
  • EUGENE SCIENCE stock
  • EUGENE SCIENCE ownership
  • EUGENE SCIENCE CEO
  • EUGENE SCIENCE documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Curanex Pharmaceuticals Inc
Update: Oct 17, 2024
Apimeds Pharmaceuticals US, Inc.
Update: Sep 26, 2024
Upstream Bio, Inc.
Update: Sep 19, 2024
Bicara Therapeutics Inc.
Update: Aug 23, 2024
Stramsen Biotech, Inc.
Update: May 21, 2024
Telix Pharmaceuticals Ltd
Update: May 18, 2024

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 4821 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 4212 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 1886 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 2282 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 2452 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 4650 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 4504 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 1292 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 3295 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by